Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 50% Off
/Free Sign Up
 0
💰 Undervalued stocks to consider before Q1 earnings
See Undervalued Stocks
Close

ProKidney Corp (PROK)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ProKidney's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1.940 -0.060    -3.00%
24/04 - Closed. Currency in USD
After Hours
1.950
+0.010
+0.515%
19:59:23 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 703,175
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.925 - 2.020
ProKidney 1.940 -0.060 -3.00%

ProKidney Option Chain

 
View the PROK options chain and compare options of ProKidney stock. Analyze the various options available, including call options (the right to buy) and put options (the right to sell), along with their strike prices and expiration dates. Evaluate the prices and premiums associated with these options to make informed decisions about your trading strategies. Assess the Open Positions chart to find information about the distribution of open options contracts for PROK stock at various strike prices and expiration dates. Gain insights into the options market sentiment and the potential trading activity surrounding the ProKidney stock.
Expiration Date:
Show:
Strike Price:
QuotesAnalysis
Apr 24, 2026 08:08PM GMT

Calls

Puts

Last Chg. Bid Ask Vol Strike Last Chg. Bid Ask Vol
0 0% 1 2 0 0.50 0 0% 0 1 0
0 0% 0.5 1.5 0 1.00 0 0% 0 1 0
0 0% 0.05 1.05 0 1.50 0 0% 0 0.15 0
1.94
 Price @ Apr 24, 2026 08:08PM GMT
0.2 0% 0 0.3 0 2.00 0.2 0% 0 0.8 0
0.1 0% 0 0.1 1 3.00 0 0% 0.55 1.55 0
0 0% 0 0.95 0 4.00 0 0% 1.55 2.55 0

Open Positions

 Calls
 Puts
© 2016 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PROK Comments

Write your thoughts about ProKidney Corp
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nader Alsamni
Nader Alsamni Jul 17, 2025 9:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lets do it
Reply
0 0
Report
Nader Alsamni
Nader Alsamni Jul 16, 2025 12:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Today will jump 5 at least
Reply
1 0
Report
Nader Alsamni
Nader Alsamni Jul 16, 2025 12:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Going 9 sooooon
Reply
1 0
Report
Patryk Burman
Patryk Burman Jul 14, 2025 5:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
In my opinion, 9 is not achievable, 6 is not even achievable at the moment, only when phase 3 is released and the result is positive, it will be even 20
Reply
1 0
Report
Nader Alsamni
Nader Alsamni Jul 14, 2025 11:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Can fly to 9 ??
Reply
1 0
Report
Nader Alsamni
Nader Alsamni Jul 14, 2025 11:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Up up
Reply
1 0
Report
Tareq Sousa
Tareq Sousa Jul 09, 2025 6:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Mybe over than 9$ fir more than 100%profit
Reply
1 0
Report
El Chapo
El Chapo Aug 12, 2024 9:07AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🚀 ProKidney (PROK) Just Surged Nearly 20%! Can It Climb From $2 to Over $14? ProKidney (PROK) just surged nearly 20% over the last two trading sessions, and they’re making big moves in the chronic kidney disease (CKD) space with two Phase 3 trials back in action. What's even more intriguing is that they didn’t just raise $140M in their latest offering—they already had $329M in the bank. Now, with $431.5M in cash and a market cap of only $500M, their cash reserves nearly match their entire valuation! A key reason for the recent price drop was the halt in their manufacturing operations, which had been paused for several months. This info, revealed in their Q2 report on August 9, also highlighted that manufacturing has now resumed. 📈 They've restarted their PROACT 1 and 2 trials, aiming to meet the unmet needs of late-stage CKD patients. ProKidney is also strategically targeting patients with advanced CKD, a niche where current therapies are insufficient, potentially positioning rilparencel as a "blockbuster" therapy. Despite competition from GLP-1 agonists, ProKidney’s focus on the most severe cases could allow it to carve out a significant market share. And get this—BofA Securities just revised their forecasts upwards for ProKidney's cell therapy drug, REACT, now expecting peak sales to hit $1.8 billion. 😲 To top it off, Pablo Legorreta, the billionaire founder of Royalty Pharma, invested €57M of his own cash into this. That’s a huge vote of confidence. With these developments, some speculate that PROK could climb back to its all-time high of $14—or even higher—by the end of the year. This stock seems to have serious potential! What do you all think? Let’s hear your thoughts!
Reply
3 0
Report
El Chapo
El Chapo Aug 08, 2024 10:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
4$ whithin the end of the month! This is a millionaire making stock!
Reply
3 0
Report
Lyudmila Key
Lyudmila Key Mar 16, 2024 3:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I bought it with my last money at 1.40, I found out only now, this prok can only go to the expense )))
Reply
3 2
Report
Nati nati
Nati nati Mar 16, 2024 3:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
you are rich now
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Apple
Continue with Google
or
Sign up with Email